Sfoglia per Rivista HAEMATOLOGICA
Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease
2020-01-01 Paraboschi, E; Khera, Av; Merlini, Pa; Gigante, L; Peyvandi, F; Chaffin, M; Menegatti, M; Busti, F; Girelli, D; Martinelli, N; Olivieri, O; Kathiresan, S; Ardissino, D; Asselta, R; Duga, S
Reply to: [Factor XI mutation and the origin of Ashkenazi Jews. Haematologica 2008; 93:e59]
2008-01-01 Zadra, G.; Asselta, R.; Tenchini, M. L.; Castaman, G.; Seligsohn, U.; Mannucci, P. M.; Duga, S.
Rescue of activated protein C-resistance phenotype by cis-acting factor V Gly2032Asp mutation
2004-01-01 Asselta, R; Bossone, A; Iannaccone, L; Duga, S; Brancaccio, V; Margaglione, M
Retrospective evaluation of dysifibrinogenemic patients at a single center: clinical features and laboratory findings
2009-01-01 Santoro, C; Leporace, Ap; Biondo, F; Plate, M; Asselta, R; Peyvandi, F; Menegatti, M; Pignoloni, P; Duga, S; Foa, R; Mazzucconi, Mg
Risk factors for Gram-negative infections in neutropenic patients.
2005-01-01 DELLA PORTA, MATTEO GIOVANNI; Malcovati, Luca
Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome
2011-01-01 DELLA PORTA, MATTEO GIOVANNI
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi
2016-01-01 Sacchi, S; Marcheselli, R; Bari, A; Buda, G; Molinari, A L; Baldini, L; Valisa, D; Cesaretti, M; Musto, P; Ronconi, S; Specchia, G; Silvestris, F; Guardigni, L; Ferrari, A; Chiappella, A; Carella, A M; Santoro, A; Di Raimondo, F; Marcheselli, L; Pozzi, S
Severe factor V deficiency caused by two novel mutations in exon 13 of factor V gene
2000-01-01 Montefusco, Mc; Duga, S; Asselta, R; Malcovati, M; van Wijk, R; van Solinge, W; Santagostino, E; Tenchini, Ml; Mannucci, Pm
Severe factor XI deficiency in the Abruzzo region of Italy is associated to different FXI gene mutations
2008-01-01 Castaman, G.; Giacomelli, S. H.; Dragani, A.; Iuliani, O.; Duga, S.; Rodeghiero, F.
Simian virus 40 and lymphoproliferative disorder.
2005-01-01 DELLA PORTA, MATTEO GIOVANNI; Malcovati, Luca
Simultaneous genotyping of coagulation factor XI type II and type III mutations by multiplex real-time polymerase chain reaction to determine their prevalence in healthy and factor XI-deficient Italians
2008-01-01 Zadra, G.; Asselta, R.; Tenchini, M. L.; Castaman, G.; Seligsohn, U.; Mannucci, P. M.; Duga, S.
Splenectomy for treatment of immune thrombocytopenic purpura.
2005-01-01 Malcovati, Luca; DELLA PORTA, MATTEO GIOVANNI
Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.
2009-01-01 DELLA PORTA, MATTEO GIOVANNI
Stem cells and stem cell transplantation
1996-01-01 Carlo-Stella, C.; Tabilio, A
STEM-CELLS AND STEM-CELL FACTOR(S)
1995-01-01 CARLO-STELLA, C.; Rizzoli, V
The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer cells represents a therapeutic target in haploidentical haematopoietic stem cell transplantation
2018-01-01 Roberto, A; Di Vito, C; Zaghi, E; Mazza, E M C; Capucetti, A; Calvi, M; Tentorio, P; Zanon, V; Sarina, B; Mariotti, J; Bramanti, S; Tenedini, E; Tagliafico, E; Bicciato, S; Santoro, A; Roederer, M; Marcenaro, E; Castagna, L; Lugli, E; Mavillo, D
The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells
2008-01-01 Zappasodi, R.; Di Nicola, M.; Carlo Stella, C.; Mortarini, R.; Molla, A.; Vegetti, C.; Albani, S.; Anichini, A.; Gianni, A.
THE IMPACT OF THE DEGREE OF ANEMIA ON SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC SYNDROME. A BASIS FOR PROGNOSTIC ASSESSMENT AND CLINICAL DECISION MAKING
2010-01-01 DELLA PORTA, MATTEO GIOVANNI
The parallel between CD45 expression and extra-medullary evolution in aggressive myeloma with high serum lactate dehydrogenase
1998-01-01 Cesana, C; Giachetti, R; Almici, C; Garau, D; Mangoni, L; Pesci, A; Carlo-Stella, C.
Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer
In corso di stampa Giaccherini, C; Marchetti, M; Masci, G; Verzeroli, C; Russo, L; Celio, L; Sarmiento, R; Gamba, S; Tartari, C J; Diani, E; Vignoli, A; Malignetti, P; Spinelli, D; Tondini, C; Barni, S; Giuliani, F; Petrelli, F; D’Alessio, A; Gasparini, G; De Braud, F; Santoro, A; Labianca, L; Falanga, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease | 1-gen-2020 | Paraboschi, E; Khera, Av; Merlini, Pa; Gigante, L; Peyvandi, F; Chaffin, M; Menegatti, M; Busti, F; Girelli, D; Martinelli, N; Olivieri, O; Kathiresan, S; Ardissino, D; Asselta, R; Duga, S | |
| Reply to: [Factor XI mutation and the origin of Ashkenazi Jews. Haematologica 2008; 93:e59] | 1-gen-2008 | Zadra, G.; Asselta, R.; Tenchini, M. L.; Castaman, G.; Seligsohn, U.; Mannucci, P. M.; Duga, S. | |
| Rescue of activated protein C-resistance phenotype by cis-acting factor V Gly2032Asp mutation | 1-gen-2004 | Asselta, R; Bossone, A; Iannaccone, L; Duga, S; Brancaccio, V; Margaglione, M | |
| Retrospective evaluation of dysifibrinogenemic patients at a single center: clinical features and laboratory findings | 1-gen-2009 | Santoro, C; Leporace, Ap; Biondo, F; Plate, M; Asselta, R; Peyvandi, F; Menegatti, M; Pignoloni, P; Duga, S; Foa, R; Mazzucconi, Mg | |
| Risk factors for Gram-negative infections in neutropenic patients. | 1-gen-2005 | DELLA PORTA, MATTEO GIOVANNI; Malcovati, Luca | |
| Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome | 1-gen-2011 | DELLA PORTA, MATTEO GIOVANNI | |
| Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi | 1-gen-2016 | Sacchi, S; Marcheselli, R; Bari, A; Buda, G; Molinari, A L; Baldini, L; Valisa, D; Cesaretti, M; Musto, P; Ronconi, S; Specchia, G; Silvestris, F; Guardigni, L; Ferrari, A; Chiappella, A; Carella, A M; Santoro, A; Di Raimondo, F; Marcheselli, L; Pozzi, S | |
| Severe factor V deficiency caused by two novel mutations in exon 13 of factor V gene | 1-gen-2000 | Montefusco, Mc; Duga, S; Asselta, R; Malcovati, M; van Wijk, R; van Solinge, W; Santagostino, E; Tenchini, Ml; Mannucci, Pm | |
| Severe factor XI deficiency in the Abruzzo region of Italy is associated to different FXI gene mutations | 1-gen-2008 | Castaman, G.; Giacomelli, S. H.; Dragani, A.; Iuliani, O.; Duga, S.; Rodeghiero, F. | |
| Simian virus 40 and lymphoproliferative disorder. | 1-gen-2005 | DELLA PORTA, MATTEO GIOVANNI; Malcovati, Luca | |
| Simultaneous genotyping of coagulation factor XI type II and type III mutations by multiplex real-time polymerase chain reaction to determine their prevalence in healthy and factor XI-deficient Italians | 1-gen-2008 | Zadra, G.; Asselta, R.; Tenchini, M. L.; Castaman, G.; Seligsohn, U.; Mannucci, P. M.; Duga, S. | |
| Splenectomy for treatment of immune thrombocytopenic purpura. | 1-gen-2005 | Malcovati, Luca; DELLA PORTA, MATTEO GIOVANNI | |
| Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. | 1-gen-2009 | DELLA PORTA, MATTEO GIOVANNI | |
| Stem cells and stem cell transplantation | 1-gen-1996 | Carlo-Stella, C.; Tabilio, A | |
| STEM-CELLS AND STEM-CELL FACTOR(S) | 1-gen-1995 | CARLO-STELLA, C.; Rizzoli, V | |
| The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer cells represents a therapeutic target in haploidentical haematopoietic stem cell transplantation | 1-gen-2018 | Roberto, A; Di Vito, C; Zaghi, E; Mazza, E M C; Capucetti, A; Calvi, M; Tentorio, P; Zanon, V; Sarina, B; Mariotti, J; Bramanti, S; Tenedini, E; Tagliafico, E; Bicciato, S; Santoro, A; Roederer, M; Marcenaro, E; Castagna, L; Lugli, E; Mavillo, D | |
| The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells | 1-gen-2008 | Zappasodi, R.; Di Nicola, M.; Carlo Stella, C.; Mortarini, R.; Molla, A.; Vegetti, C.; Albani, S.; Anichini, A.; Gianni, A. | |
| THE IMPACT OF THE DEGREE OF ANEMIA ON SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC SYNDROME. A BASIS FOR PROGNOSTIC ASSESSMENT AND CLINICAL DECISION MAKING | 1-gen-2010 | DELLA PORTA, MATTEO GIOVANNI | |
| The parallel between CD45 expression and extra-medullary evolution in aggressive myeloma with high serum lactate dehydrogenase | 1-gen-1998 | Cesana, C; Giachetti, R; Almici, C; Garau, D; Mangoni, L; Pesci, A; Carlo-Stella, C. | |
| Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer | In corso di stampa | Giaccherini, C; Marchetti, M; Masci, G; Verzeroli, C; Russo, L; Celio, L; Sarmiento, R; Gamba, S; Tartari, C J; Diani, E; Vignoli, A; Malignetti, P; Spinelli, D; Tondini, C; Barni, S; Giuliani, F; Petrelli, F; D’Alessio, A; Gasparini, G; De Braud, F; Santoro, A; Labianca, L; Falanga, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile